Clinical Trial Update: A Stratified Sickle Event Randomized Trial (ASSERT) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial in sickle cell disease (ASSERT) sponsored by Icagen has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Icagen | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED